you're reading...
Economic and Social Policies, International Relations, PUBLICATIONS

Ebola – one year on

Written by Nicole Scholz
Ebola tag cloud

© JPchret / Fotolia

This week (3 March) Guinea, Sierra Leone and Liberia, along with Togo, host a high level international conference in Brussels on the fight against Ebola. Delegations will attend from all the West African states, EU Member States, UN agencies, the World Bank, IMF and the various NGOs, private-sector actors (such as pharmaceutical companies) and research institutes. At this stage in the epidemic, participants will be keen to identify priorities and coordinate the humanitarian aid offered by the international community. High on the agenda will be lessons learned for prevention of further outbreaks, and progress on finding both treatments and vaccines.

The Science and Technology Options Assessment (STOA) Panel has convened a workshop in the European Parliament in Brussels for the day after the conference, on 4 March, drawing together experts from international institutions, NGOs and European political parties to discuss this issue in depth. The workshop will focus on the importance of surveillance, rapid diagnostic testing for Ebola and the prospects for vaccination against the disease. It also provides an opportunity to deliberate upon the importance of Ebola research alongside competing research priorities and the lessons already being learned to prevent future crises from arising.

This latest outbreak left more than 9 500 people dead and families and fragile economies shattered, mainly in West Africa – Guinea, Liberia and Sierra Leone.

As yet, there is no approved medicine to treat Ebola. Simple, yet highly effective containment measures remain the cornerstone of efforts to control the outbreak. Development of therapeutic approaches is progressing rapidly, but may not be in time to change the course of this disastrous epidemic. Trials for an Ebola vaccine have started, but are still in their early stages.

The EU and its Member States pledged €1.2 billion to finance efforts to fight the disease, and a further €414 million for emergency measures, long-term support and the development of both treatments and vaccines.

Lire notre note “En bref”: “Ebola – un an après“.

Discussion

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,005 other followers

RSS Link to Members’ Research Service

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.

%d bloggers like this: